Expansion of Seattle Lymph Node Project
The National Institute of Allergy and Infectious Diseases (NIAID) in support of the Vaccine Research Center (VRC) intends to negotiate on an other than full and open basis with the University of Washington, 325 9th Ave, Seattle, WA 98104, for an expansion of the Seattle Lymph Node Project, involving a collection of lymph nodes from HIV infected subjects.
This Lymph Node Project involves the testing of lymph nodes, PBMCs, and plasma samples from the Seattle cohort for processing and further testing and analysis by the Vaccine Research Center.
This acquisition will be processed under FAR Part 12 - Acquisition for Commercial Items and will be made pursuant to the authority in FAR Part 13.501 (a)(1).
Only one award will be made as a result of this solicitation.
This will be a firm fixed price award.
FOB Point shall be Destination: 40 Convent Drive, Bethesda, Maryland 20892.
Period of Performance: One Year from Award Date
The statutory authority for this sole source requirement is 41 U.S.C. 253 (c) (1) as implemented by FAR 6.302-1 only one source available, no substitutions possible. THIS IS NOT A SOLICITATION FOR COMPETITIVE QUOTATIONS. All responsible sources who can provide the same service may submit a response that could be considered by email (subject line to reference NIAID-NOI-18-1907446) to Akilah Bullock at akilah.bullock@nih.gov, by 1:00 pm eastern standard time Monday, June 25, 2018. All information furnished must be in writing and must contain sufficient detail to allow NIAID to determine if it can meet the above unique specifications described herein. All responses received by the closing date of this solicitation will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
Akilah Bullock, Contract Specialist, Phone 3017617500, Email akilah.bullock@nih.gov
